Reviewed profile

food and beverage brand · public preview

Alprase Products

Retail brand

Public category
Retail brand
Products tracked
1
Brand tier
mainstream brand
Headquarters
Japan
Is this your company?Claim Alprase Products to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Alprase Products — no cold outreach.
Report a changeLog in for full recordLast reviewed 25 Apr 2026 · public preview data

Overview

What Alprase Products covers.

Elaprase (idursulfase) is a prescription enzyme replacement therapy indicated for the treatment of Hunter syndrome (mucopolysaccharidosis II). Developed and marketed by Takeda Pharmaceutical Company, the medication is designed to address the underlying enzyme deficiency in patients of various ages. It is administered via intravenous infusion under medical supervision due to the risk of serious allergic reactions.

  • Talio tracks 1 product for Alprase Products.
  • Positioned as a mainstream brand.
  • Headquartered in Japan.

FAQ

Questions this page answers.

What does Alprase Products do?

Alprase Products is a food and beverage brand based in Japan, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.